भारतीय भेषज संहिता आयोग
IPC, NCC-PvPI Concludes 5th National Pharmacovigilance Week with Valedictory Ceremony at Ghaziabad
The National Coordination Centre for Pharmacovigilance Programme of India (NCC-PvPI) at Indian Pharmacopoeia Commission (IPC) organized the 5th National Pharmacovigilance Week (NPW) from 17th to 23rd September 2025. The program was inaugurated on 17th September 2025 at Bharat Mandapam Convention Centre, New Delhi, in alignment with World Patient Safety Day, on the theme “Your Safety, Just a Click Away: Report to PvPI.” The week-long program concluded on 23rd September 2025 with a valedictory ceremony held at IPC, Ghaziabad in hybrid mode.
The valedictory ceremony commenced with a welcome address by Dr. Jai Prakash, Senior Principal Scientific Officer & Officer-in-Charge, PvPI, who emphasized the role of PvPI in ensuring patient safety and encouraged continued commitment from stakeholders.
This was followed by an address by Mr. Daara B. Patel, Secretary General, Indian Drugs Manufacturers Association (IDMA) on “Strengthening Industry-Driven Pharmacovigilance: Challenges and Way Ahead,” who emphasized on strengthening pharmacovigilance systems within the pharmaceutical industry and ways to enhance reporting to PvPI.
Next, Dr. Upasana Arora, CEO and Managing Director, Yashoda Super Speciality Hospital, Ghaziabad, highlighted the importance of collaborative efforts between hospitals, regulators, and industry to strengthen Adverse Drug Reaction (ADR) reporting mechanisms.
The ceremony also featured the felicitation of top-performing Adverse Drug Reaction Monitoring Centres (AMCs) under PvPI and Marketing Authorization Holders (MAHs) reporting ADRs to PvPI, recognizing their contributions to strengthening ADR reporting and patient safety. This was followed by an audio-visual presentation on the Glimpses of 5th NPW Celebrations, showcasing the nationwide activities conducted during the week. Subsequently, many participants shared their insights and reflections, further enriching the deliberations of the session.
In his concluding remarks, Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, reflected on the progress made during 5th NPW and reiterated IPC’s commitment to developing innovative tools, expanding outreach, and capacity-building for pharmacovigilance in India.
The session concluded with a vote of thanks by Dr. Shashi Bhushan, Senior Scientific Officer, IPC, who acknowledged the contributions of dignitaries, experts, partner institutions, and stakeholders from across the country.
IPC, NCC-PvPI conveys its sincere gratitude to all stakeholders and the Ministry of Health and Family Welfare, Government of India, for their unwavering support in making the 5th NPW a resounding success.
